Health PolicyLesson PlanCivics

How to Teach FDA Policy and Pharmaceutical Risk Using Pharmalot Stories

cclassroom

2026-02-12

10 min read

Turn STAT's Pharmalot reporting into a civics lesson: teach FDA expedited review, pharma risk, and legal debates with ready-to-use activities and rubrics.

Teach FDA Policy and Pharmaceutical Risk with a Pharmalot Case Study — Fast, Clear, Classroom-Ready

Teachers and curriculum designers: you need ready-to-use lessons that make complex health policy tangible, save planning time, and spark real civic debate. This lesson plan package turns STAT's Pharmalot reporting from late 2025 and early 2026 into a high-engagement civics and health policy unit that explains FDA policy, expedited review programs, and corporate pharma risk decisions — while centering the legal and ethical questions journalists flagged in 2026.

What you’ll get in this article

A concise 2026-oriented primer on expedited review and legal risk
A step-by-step, standards-aligned lesson plan with time estimates
Active learning activities (debates, role plays, risk assessments)
Rubrics, student handouts, and primary-source suggestions
Classroom-ready assessment and differentiation strategies

Why this matters now (2026): the context teachers need

In late 2025 and early 2026, reporters at STAT's Pharmalot documented how several major drugmakers were weighing participation in a recent federal program designed to accelerate drug reviews. The coverage highlighted a tension now central to health policy classrooms: the tradeoff between speeding access to potentially lifesaving medicines and the legal, financial, and reputational risks companies face when regulators cut review timelines.

Pharmalot reporting in January 2026 noted that some drugmakers hesitated to join a speedier review program because of possible legal exposure and post-market obligations. These real-world decisions provide rich material for civics lessons.

Use this unit to help students evaluate how policy, science, markets, and law intersect — and to practice civic skills like evidence-based debate, policy analysis, and persuasive writing.

Teacher primer: The evolution of expedited review (short, 2026 lens)

By 2026 the federal regulatory landscape has emphasized faster approvals paired with stronger post-market surveillance and real-world evidence (RWE) collection. Longstanding pathways — Priority Review, Accelerated Approval, and Breakthrough Therapy designations — coexist with newer initiatives that aim to streamline cross-agency and international reviews. Policymakers and companies now balance speed with:

heightened post-market data requirements;
expanded civil litigation and securities scrutiny (reported cases in 2025–2026 raised industry awareness); and
increased public demand for transparency.

These changes make a classroom case study unusually timely: students can explore how regulatory design influences corporate strategy and public health outcomes.

Learning objectives & alignment

Use these objectives to guide assessment and align to civics, social studies, and health standards.

Students will explain how FDA expedited review programs work and why policymakers use them.
Students will analyze the legal and reputational risks companies face when participating in accelerated programs.
Students will evaluate policy choices from multiple stakeholder perspectives and write a policy memo with evidence-based recommendations.
Students will practice civic discourse through structured debate and role play.

Unit snapshot (1–2 week sequence)

Grade levels: 9–12, AP Government, or undergraduate introductory health policy
Estimated time: 4–8 class periods (45–60 min each)
Materials: printed Pharmalot excerpts (Jan 2026), FDA guidance pages, company press releases, case law summaries, digital tools for collaboration

Lesson activities — step-by-step

Activity 1: Source jigsaw and timeline (45–60 min)

Goal: Build shared factual grounding using contemporary reporting and primary documents.

Assign groups to one of these source packs: (A) Pharmalot article(s) from Jan 2026, (B) FDA guidance on expedited pathways (official site), (C) a company press release about participating or opting out, (D) a short legal brief or news summary about corporate litigation or securities concerns from 2025–2026.
Each group reads and prepares a 3–4 minute summary: key facts, stakeholder positions, legal questions raised, and timeline items.
Groups rotate and teach peers; class builds a shared timeline on the board or Jamboard that traces policy announcements, company decisions, and media coverage.

Activity 2: Mock FDA advisory hearing / role-play debate (2 class periods)

Goal: Practice deliberative democracy and policy advocacy.

Assign roles: FDA regulator, pharmaceutical CEO, chief legal officer, patient advocate, public health researcher, journalist, and member of Congress. Provide role cards with evidence-based talking points.

Round 1 (45 min): Opening statements and Q&A. Regulators explain tradeoffs; companies explain why they would or would not participate in an expedited program.
Round 2 (45 min): Cross-examination, public comment, and committee vote (class votes on whether the program should continue, be revised, or halted).

Grading rubric (use a 12-point scale): clarity of evidence (4), persuasiveness/role fidelity (4), civility and rebuttal (4).

Activity 3: Corporate risk assessment workshop (60–75 min)

Goal: Students learn to identify legal, financial, and reputational risks and propose mitigation strategies.

Provide a short hypothetical: a mid-size company has a promising diabetes drug and has been invited to a new speedier review program that requires earlier market commitments and enhanced RWE reporting.
Small groups map risks into categories: regulatory compliance, product liability, securities/insider trading risk, PR and stakeholder backlash, and operational/clinical risks.
Groups propose a mitigation plan (legal safeguards, transparency measures, staged commitments, insurance strategies) and pitch it to the class.

Activity 4: Policy memo (homework; 1–2 class periods to peer review)

Goal: Produce evidence-based policy advice for a member of Congress or the FDA commissioner.

Student memo structure (one page): Context (1–2 sentences), Problem (one paragraph), Options (3–4 options with pros/cons), Recommendation (clear), Implementation checklist (5 bullets), Sources (3–5).

Activity 5: Reflective exit ticket & formative quiz (15 min)

Sample exit ticket prompts:

One sentence: what is the biggest legal risk when a company speeds a drug to market?
One concrete change to the expedited program you would recommend and why.

Assessment tools & rubrics

Use three assessment strands: Content Mastery (40%), Civic Skills (30%), Communication (30%).

Content Mastery: accurately describes expedited pathways and post-market obligations; uses at least two primary sources (40 pts).
Civic Skills: demonstrates role empathy, counters arguments with evidence, and follows deliberation norms (30 pts).
Communication: memo clarity, citation quality, and presentation polish (30 pts).

Primary sources and further reading (teacher toolkit)

Recommended items to share with students:

Selected Pharmalot pieces from late 2025 / Jan 2026 that discuss industry hesitation and legal concerns (use STAT links in your LMS).
FDA public guidance pages on Priority Review, Accelerated Approval, and RWE — use official FDA.gov materials for accuracy.
Congressional reports and GAO summaries on expedited approvals (search GAO 2023–2026 reviews).
Short legal summaries of recent industry litigation or securities probes referenced in news (for classroom discussion only; avoid legal advice).

Digital tools and 2026 classroom trends

Leverage current edtech to save time and increase engagement:

Hypothesis (annotate news articles collaboratively)
Google Docs + commenting for peer review
Jamboard or Padlet for timeline building
AI summarizers (use responsibly): have students compare a generative-AI summary to the original Pharmalot reporting and critique accuracy and bias — teach source evaluation in the AI era.

In 2026, classrooms increasingly integrate generative AI for drafting and feedback. Use AI as a scaffold — not a substitute. Require students to cite original sources and explain how the AI output differed from the primary reporting.

Differentiation and inclusion

Adapt the unit for diverse learners and multilingual students:

Provide simplified article versions or audio recordings of the Pharmalot piece.
Offer role cards with sentence starters for oral presentations.
Use mixed-ability groups and assign clear, scaffolded tasks (research, summarizer, presenter).
Allow alternative products: visual infographic, podcast episode, or short video memo for students who struggle with long essays.

Classroom safety and legal considerations

When teaching contemporary news and legal claims, follow these safeguards:

Use reputable sources and teach students to verify facts across multiple outlets.
Frame legal items as reported allegations or cases — avoid presenting unresolved litigation as proven fact.
Remind students this is a civics and policy analysis exercise, not legal advice.

Sample student prompts and debate positions

Use these to jump-start discussion and assessments.

Prompt for a short essay: "Given the tradeoffs between faster access and higher post-market obligations, should the FDA expand expedited pathways? Defend your position with evidence."
Debate resolution: "This committee should recommend that the federal expedited review program require mandatory product liability insurance for participating firms."
Role-play prompt: "You are a patient advocate whose relative may benefit from the new drug. How do you weigh speed vs. safety?"

Actionable takeaways for busy teachers

Start with a single class period: do the jigsaw and timeline. That creates a week’s unit in one lesson.
Use role cards to save prep time — provide one-page briefs for each role.
Leverage AI to generate formative quiz questions and sample rubrics, but always verify facts against primary sources.
Emphasize evidence: require at least two primary sources in every student product.

Common challenges and quick fixes

Teachers often worry about: (1) legal complexity, (2) lack of science background, and (3) limited class time. Quick fixes:

Legal complexity: focus on the concept of risk rather than legal minutiae; use hypothetical scenarios for application exercises.
Science background: provide a 1-page primer on clinical trial phases and endpoints; invite a school nurse or local public health official for a 20-minute Q&A.
Time limits: compress the unit to a 1–2 day debate plus a 1-page memo if needed.

Teacher example: 2-day compressed plan

Day 1: Jigsaw sources (30–40 min) + prepare positions for debate (homework)
Day 2: Mock hearing and vote (60–90 min) + 1-page policy memo due next class

Why this lesson works: pedagogy and civic impact

This unit combines case-based learning and deliberative pedagogy — two approaches shown to increase evidence-based reasoning and civic engagement. Using a real-world news lens (turning a live launch into a viral micro-documentary) gives students authentic tasks: interpreters of complex documents, advocates balancing competing goods, and critical consumers of media in the AI age.

Next steps & additional resources

To expand the unit, invite a local expert panel (public health, bioethics, or an attorney) or assign a capstone project where students draft a short op-ed for the local paper arguing a policy position.

Final checklist for teachers

Download and print the Pharmalot excerpt and FDA guidance pages for students.
Create role cards and distribute them 24 hours before the debate.
Prepare a rubric and share it with students in advance.
Plan one formative assessment using AI-generated questions, then verify and edit them.

Closing thoughts

As 2026 reporting shows, decisions around expedited review are not only scientific — they are legal, economic, and deeply civic. Turning STAT’s Pharmalot coverage into classroom practice helps students see how policy shapes real choices in industry and public health, and gives them the tools to analyze those choices critically.

Ready-to-use materials: Use the activities above as a scaffold today: run the jigsaw in one period and the mock hearing the next. Your students will leave with sharper skills in policy analysis, argumentation, and media literacy.

Try the unit this month and share student products with our teacher community — or request the printable lesson packet and rubric from classroom.top for an editable Google Docs package.

Call to action

Download the full lesson pack, role cards, and rubrics at classroom.top/lessonpacks (or email us to request the editable files). Teach one civics lesson that equips students to analyze real-world tradeoffs at the heart of health policy, and then share student work with our community so we can refine and expand together.

classroom

Contributor

Senior editor and content strategist. Writing about technology, design, and the future of digital media. Follow along for deep dives into the industry's moving parts.